June 28, 2020
Meeting Increased Testing Needs for Public Health Supply Chains – Building More Responsive, Efficient, and Resilient Diagnostic NetworksFor better and for worse, testing is having a moment. The COVID-19 pandemic has shined a bright light on an area of healthcare that was often an afterthought. In fact, accurate and timely diagnosis of disease is one of the foundational pieces of good medicine. And given significant CapEx investment requirements for equipment, uncertain demand, cost/service trade-offs, capacity and operational constraints, and a rapidly changing medical and technological landscape, these diagnostic supply chains face many of the same challenges that are seen in commercial industries. Whether it is testing for COVID-19, HIV, tuberculosis, or a combination of all three, LLamasoft has done extensive work analyzing and designing these testing networks for improved performance.
In partnership with the Foundation for Innovative New Diagnostics (FIND), LLamasoft’s Supply Chain Guru software was used to model a variety of supply chain scenarios for the Lesotho Ministry of Health’s TB program. The results of this work were recently published in the journal PLOS ONE:
Read the full article by clicking on the link below.